This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor View responses Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coutant, R. Articles by Morel, Y. Search for Related Content PubMed PubMed Citation Articles by Coutant, R. Articles by Morel, Y. Related Collections Pediatric Endocrinology Male Endocrinology

Heterozygous Mutation of Steroidogenic Factor-1 in 46,XY Subjects May Mimic Partial Androgen Insensitivity Syndrome

Pediatric Endocrinology Department and Centre of Reference for Pathologies in Hormonal Receptivity (R.C., N.B.-N.), and Departments of Genetics (A.G.), Pediatric Surgery (L.C.), and Pathology (A.C.), University Hospital, 49033 Angers, France; Molecular Biology and Hormonology Department (D.M., Y.M.), Debrousse Hospital, 69000 Lyon, France; and Department of Pediatric Hormonology and Metabolic Diseases (N.L.), Saint Vincent de Paul Hospital, 75014 Paris, France

Address all correspondence and requests for reprints to: Régis Coutant, Department of Pediatric Endocrinology, University Hospital, 4 rue Larrey, 49033 Angers CEDEX 01, France. E-mail: recoutant{at}chu-angers.fr.

Context: The clinical and biological features of Sertoli cell and Leydig cell dysfunction are usually investigated when characterizing disorders of sex development in 46,XY individuals: This allows gonadal dysgenesis, a defective development of the gonad, to be distinguished from defects restricted to androgen synthesis or sensitivity. In humans, mutations in steroidogenic factor-1 (SF-1), one of the critical factors involved in testis development, have been reported to cause gonadal dysgenesis with or without adrenal failure in 46,XY individuals.

Objective: We report a SF-1 mutation that caused ambiguous genitalia associated with strikingly different hormonal phenotypes in two affected 46,XY children from the same family.

Methods: Hormonal evaluation included testosterone (T), anti-Mullerian hormone (AMH), inhibin B, FSH, and LH measurements during the first weeks of life, a period when physiological activation of the gonadotropin-gonadal system occurs. Direct DNA sequencing of the coding sequence of the SF-1 and the androgen receptor (AR) genes was performed.

Results: Both 46,XY children had ambiguous genitalia with no Mullerian structures and no adrenal insufficiency. The older child showed normal elevation of T (up to 7.6 nmol/liter, 2.2 ng/ml), AMH (504 pmol/liter, 70.6 ng/ml), inhibin B (245 pg/ml), FSH, and LH during the first weeks, which led to a presumptive diagnosis of partial androgen insensitivity syndrome. The AR sequence was, however, normal. In the second child, T, AMH, and inhibin B were low, suggesting gonadal dysgenesis. In both children and their mother, a c.536delC frameshift mutation in the SF-1 gene was found. This mutation terminates translation at position 295, removing the ligand-binding domain and the activation function 2 (AF-2) domain, a critical domain for SF-1 transactivating activity.

Conclusions: The usual markers of testis dysgenesis may be normal in 46,XY individuals with SF-1 mutation. Screening for SF-1 mutation should be performed in subjects with apparent partial androgen insensitivity syndrome and no mutation in the AR gene.

This article has been cited by other articles:

				C. Pelusi, Y. Ikeda, M. Zubair, and K. L. Parker Impaired Follicle Development and Infertility in Female Mice Lacking Steroidogenic Factor 1 in Ovarian Granulosa Cells Biol Reprod, December 1, 2008; 79(6): 1074 - 1083. [Abstract] [Full Text] [PDF]

eLetters: